glp-1 regulatory news GLP-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo obesity drug news today glp-1

Patel does not think clinicians should jump the gun and suggest discontinuing these meds, especially if they are used for treatment of diabetes

Morrow, N

Originally designed for diabetes management, these drugs have demonstrated efficacy in achieving significant weight loss

A large international study suggests that a subset of people with Type 2 diabetes carry genetic variants that blunt the effectiveness of widely used GLP-1based drugs, despite unexpectedly elevated levels of the hormone in their bodies

When to stop Discontinue and seek medical attention if you experience: severe abdominal pain that does not resolve, persistent vomiting, signs of pancreatitis, changes in vision, or any allergic reaction (difficulty breathing, swelling of face or throat)

Over weeks, that gap compounds